Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Interest Expenses (2016 - 2025)

Standard Biotools (LAB) has disclosed Interest Expenses for 16 consecutive years, with $10000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses fell 98.83% to $10000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $593000.0, a 84.57% decrease, with the full-year FY2024 number at $3.3 million, down 27.39% from a year prior.
  • Interest Expenses was $10000.0 for Q3 2025 at Standard Biotools, up from $9000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $2.2 million in Q2 2023 to a low of $2000.0 in Q1 2025.
  • A 5-year average of $845157.9 and a median of $968000.0 in 2021 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: soared 1650.85% in 2024, then tumbled 99.81% in 2025.
  • Standard Biotools' Interest Expenses stood at $1.1 million in 2021, then increased by 11.01% to $1.2 million in 2022, then fell by 7.73% to $1.1 million in 2023, then crashed by 47.91% to $572000.0 in 2024, then crashed by 98.25% to $10000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Interest Expenses are $10000.0 (Q3 2025), $9000.0 (Q2 2025), and $2000.0 (Q1 2025).